Literature DB >> 30348692

How Much Ischemia Can the Severely Steatotic Rat Liver Tolerate?

Ioannis D Kostakis1,2, Nikolaos Sikalias3, Konstantinos Alexiou3, Lamprini Mountzalia3, Apostolos Papalois4, Theodore Karatzas5,2.   

Abstract

AIM: Steatotic liver is more susceptible to ischemia-reperfusion injury than is lean liver. Our aim was to investigate the ability of the severely steatotic rat liver to sustain ischemia.
MATERIALS AND METHODS: One hundred male Wistar rats aged 12-14 weeks were included. Fifty rats were given regular diet, while the rest were given a choline-free diet for 12-14 weeks to develop severe liver steatosis. Each group was divided into the following five subgroups: Sham-operated, and 5, 10, 15 and 20 minutes of continuous vascular inflow occlusion. Serum glutamic-oxaloacetic transaminase and serum glutamic-pyruvic transaminase levels were measured at 24 hours postoperatively and the animals were surveilled for 30 days.
RESULTS: Serum transaminase levels increased as the duration of ischemia increased in lean livers (p<0.0001), without a significant impact on animal survival. Similarly, serum transaminase levels increased as the duration of ischemia increased in severely steatotic livers (p<0.0001), reaching a plateau after 15 minutes of liver ischemia. Survival was significantly affected after the same cut-off point in rats with steatotic liver (p<0.0001). Serum transaminase levels were greater in severely rats with steatotic liver than in rats with lean liver, when they were adjusted for the duration of liver ischemia. Moreover, survival was reduced when serum transaminase levels surpassed the threshold of 2,000 IU/l (p<0.0001).
CONCLUSION: Severely steatotic rat liver can safely tolerate up to 10 minutes of continuous ischemia, with survival being affected after 15 minutes or more. On the other hand, lean rat liver can safely tolerate even 20 minutes of continuous ischemia. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Liver; fatty liver disease; ischemia; ischemia-reperfusion injury; rats; steatosis

Mesh:

Substances:

Year:  2018        PMID: 30348692      PMCID: PMC6365744          DOI: 10.21873/invivo.11390

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  31 in total

Review 1.  Steatosis as a risk factor in liver surgery.

Authors:  Reeta Veteläinen; Arlène van Vliet; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

2.  Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy.

Authors:  Reeta Veteläinen; Arlène K van Vliet; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

3.  Ischemia-reperfusion injury in rat fatty liver: role of nutritional status.

Authors:  P Caraceni; B Nardo; M Domenicali; P Turi; M Vici; M Simoncini; N De Maria; F Trevisani; D H Van Thiel; M Derenzini; A Cavallari; M Bernardi
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

Review 4.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

5.  Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.

Authors:  Anna Serafín; Joan Roselló-Catafau; Neus Prats; Carme Xaus; Emilio Gelpí; Carmen Peralta
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.

Authors:  Reeta Veteläinen; Arlène van Vliet; Thomas M van Gulik
Journal:  J Gastroenterol Hepatol       Date:  2007-09       Impact factor: 4.029

7.  Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers.

Authors:  Marta Massip-Salcedo; Araní Casillas-Ramirez; Rosah Franco-Gou; Ramón Bartrons; Ismail Ben Mosbah; Anna Serafin; Joan Roselló-Catafau; Carmen Peralta
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion.

Authors:  Anna Serafín; Joan Roselló-Catafau; Neus Prats; Emilio Gelpí; Joan Rodés; Carmen Peralta
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

Review 9.  Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

Authors:  Quentin M Anstee; Robert D Goldin
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

10.  Up regulation of IL-6 by ischemic preconditioning in normal and fatty rat livers: association with reduction of oxidative stress.

Authors:  Lorenza Tacchini; Gaetano Cairo; Cristina De Ponti; Marta Massip; Joan Rosellò-Catafau; Carmen Peralta
Journal:  Free Radic Res       Date:  2006-11
View more
  2 in total

Review 1.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Role of hepatic stellate cells in liver ischemia-reperfusion injury.

Authors:  Yuming Peng; Qiang Yin; Miaoxian Yuan; Lijian Chen; Xinyi Shen; Weixin Xie; Jinqiao Liu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.